{'Year': '2021', 'Month': 'Oct'}
Potentially actionable pharmacogenetic variants and symptom control medications in oncology.
We estimated the prevalence of potentially actionable pharmacogenetic (PGx) variants related to symptom control medications (SCMs) based on institutional prescribing patterns and correlated presenting symptoms with SCM prescribing.